Global and China Drugs for Treatment of Breast Cancer Research Report to 2020
The global Drugs for Treatment of Breast Cancer market was valued at USD 142 Billion in 2015, and is projected to reach USD 210 Billion by 2021, at a CAGR of 8.14% between 2016 and 2021. Ibrance, the drug star of Pfizer will become a major growth point. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs
This report studies Drugs for Treatment of Breast Cancer in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production market share of Drugs for Treatment of Breast Cancer in Established markets, Europe, Emerging Markets and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Faslodex
Hercepti
Perjeta
Kadcyla
Afinitor
Avastin
Tamoxifen Citrate Tablets
Exemestane Tablets
Letrozol Tablets
Capecitabine Tablets
Ibrance
Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Breast Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Roche
Pfizer
Novartis
AstraZeneca
Yangtze River Pharmaceutical Group
FORWARD
NT Pharma
Jiang Su Heng Rui Medicine
Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering
Established markets
Europe
Emerging Markets
China
With 140pages, 118 charts and eight chapters, to display the market present situation and future, clearly and deeply.
This report studies Drugs for Treatment of Breast Cancer in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production market share of Drugs for Treatment of Breast Cancer in Established markets, Europe, Emerging Markets and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Faslodex
Hercepti
Perjeta
Kadcyla
Afinitor
Avastin
Tamoxifen Citrate Tablets
Exemestane Tablets
Letrozol Tablets
Capecitabine Tablets
Ibrance
Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Breast Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Roche
Pfizer
Novartis
AstraZeneca
Yangtze River Pharmaceutical Group
FORWARD
NT Pharma
Jiang Su Heng Rui Medicine
Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering
Established markets
Europe
Emerging Markets
China
With 140pages, 118 charts and eight chapters, to display the market present situation and future, clearly and deeply.
Global and China Drugs for Treatment of Breast Cancer Research Report to 2020
1 DRUGS FOR TREATMENT OF BREAST CANCER OVERVIEW AND EACH TYPE
1.1 Product Overview of Drugs for Treatment of Breast Cancer
1.1.1 Definition and Product Scope of Drugs for Treatment of Breast Cancer
1.1.2 Global Market Size (Value and Volume) of Drugs for Treatment of Breast Cancer 2015-2020
1.1.3 China Market Size (Value and Volume) of Drugs for Treatment of Breast Cancer 2015-2020
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List of Each Type in 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Faslodex Specification and Price in 2015 and 2016
1.2.5 Hercepti Specification and Price in 2015 and 2016
1.2.6 Perjeta Specification and Price in 2015 and 2016
1.2.7 Kadcyla Specification and Price in 2015 and 2016
1.2.8 Afinitor Specification and Price in 2015 and 2016
1.2.9 Avastin Specification and Price in 2015 and 2016
1.2.10 Tamoxifen Citrate Tablets Specification and Price in 2015 and 2016
1.2.11 Exemestane Tablets Specification and Price in 2015 and 2016
1.2.12 Letrozol Tablets Specification and Price in 2015 and 2016
1.2.13 Capecitabine Tablets Specification and Price in 2015 and 2016
1.2.14 Ibrance Specification and Price in 2015 and 2016
1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.3.1 Price List (Interviewed) of Faslodex by Key Manufacturers
1.3.2 Price List (Interviewed) of Hercepti by Key Manufacturers
1.3.3 Price List (Interviewed) of Perjeta by Key Manufacturers
1.3.4 Price List (Interviewed) of Kadcyla by Key Manufacturers
1.3.5 Price List (Interviewed) of Afinitor by Key Manufacturers
1.3.6 Price List (Interviewed) of Avastin by Key Manufacturers
1.3.7 Price List (Interviewed) of Tamoxifen Citrate Tablets by Key Manufacturers
1.3.8 Price List (Interviewed) of Exemestane Tablets by Key Manufacturers
1.3.9 Price List (Interviewed) of Letrozol Tablets by Key Manufacturers
1.3.10 Price List (Interviewed) of Capecitabine Tablets by Key Manufacturers
1.3.11 Price List (Interviewed) of Ibrance by Key Manufacturers
2 COMPETITION ANALYSIS BY MANUFACTURERS IN GLOBAL AND CHINA
2.1 Global Market Drugs for Treatment of Breast Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Drugs for Treatment of Breast Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Drugs for Treatment of Breast Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.5 China Market Drugs for Treatment of Breast Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.6 China Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
3 SALES AND REVENUE SEGMENTS OF EACH TYPE 2015 TO 2016
3.1 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.1.1 Global Sales and Market Share of Each Type 2015 to 2016
3.1.2 Global Revenue and Market Share of Each Type 2015 to 2016
3.2 Faslodex Sales and Growth Rate 2015 to 2020
3.3 Hercepti Sales and Growth Rate 2015 to 2020
3.4 Perjeta Sales and Growth Rate 2015 to 2020
3.5 Kadcyla Sales and Growth Rate 2015 to 2020
3.6 Afinitor Sales and Growth Rate 2015 to 2020
3.7 Avastin Sales and Growth Rate 2015 to 2020
3.8 Tamoxifen Citrate Tablets Sales and Growth Rate 2015 to 2020
3. 9 EXEMESTANE TABLETS SALES AND GROWTH RATE 2015 TO 2020
3.10 Letrozol Tablets Sales and Growth Rate 2015 to 2020
3.11 Capecitabine Tablets Sales and Growth Rate 2015 to 2020
4 MARKET SEGMENTS AND FORECAST OF DRUGS FOR TREATMENT OF BREAST CANCER BY REGIONS
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
4.1.1 Sales and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2 Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2.1 Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.3 Established ROW Market Forecast to 2020
4.3.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.4 Europe Market Forecast to 2020
4.4.1 Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.5 Emerging Markets Market Forecast to 2020
4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.8 China Market Forecast to 2020
4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
5 RAW MATERIALS AND APPLICATIONS
5.1 Key Raw Materials and Price Analysis for Faslodex
5.1.1 Key Raw Materials for Faslodex
5.1.2 Price Forecast of Key Raw Materials for Faslodex 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Hercepti
5.2.1 Key Raw Materials for Hercepti
5.2.2 Price Forecast of Key Raw Materials for Hercepti 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Perjeta
5.3.1 Key Raw Materials for Perjeta
5.3.2 Price Forecast of Key Raw Materials for Perjeta 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Kadcyla
5.4.1 Key Raw Materials for Kadcyla
5.4.2 Price Forecast of Key Raw Materials for Kadcyla 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Afinitor
5.5.1 Key Raw Materials for Afinitor
5.5.2 Price Forecast of Key Raw Materials for Afinitor 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Avastin
5.6.1 Key Raw Materials for Avastin
5.6.2 Price Forecast of Key Raw Materials for Avastin 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Tamoxifen Citrate Tablets
5.7.1 Key Raw Materials for Tamoxifen Citrate Tablets
5.7.2 Price Forecast of Key Raw Materials for Tamoxifen Citrate Tablets 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Exemestane Tablets
5.8.1 Key Raw Materials for Exemestane Tablets
5.8.2 Price Forecast of Key Raw Materials for Exemestane Tablets 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Letrozol Tablets
5.9.1 Key Raw Materials for Letrozol Tablets
5.9.2 Price Forecast of Key Raw Materials for Letrozol Tablets 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Capecitabine Tablets
5.10.1 Key Raw Materials for Capecitabine Tablets
5.10.2 Price Forecast of Key Raw Materials for Capecitabine Tablets 2016 to 2021
5.11 Key Raw Materials and Price Analysis for Ibrance
5.11.1 Key Raw Materials for Ibrance
5.11.2 Price Forecast of Key Raw Materials for Ibrance 2016 to 2021
5.12 Applications of Faslodex
5.13 Applications of Hercepti
5.14 Applications of Perjeta
5.15 Applications of Kadcyla
5.16 Applications of Afinitor
5.17 Applications of Avastin
5.18 Applications of Tamoxifen Citrate Tablets
5.19 Applications of Exemestane Tablets
5.20 Applications of Letrozol Tablets
5.21 Applications of Capecitabine Tablets
5.22 Applications of Ibrance
6 KEY MANUFACTURERS ANALYSIS OF DRUGS FOR TREATMENT OF BREAST CANCER
6.1 AstraZeneca
6.1.1 Company Basic Information
6.1.2 Faslodex (Specification and Price)
6.1.2.1 Faslodex 5ml:0.25g, Price, Sales Value and Market Share of AstraZeneca
6.1.3 Sales Value, Gross Margin 2011-2016
6.1.3.1 Sales Value, Gross Margin and Growth rate of AstraZeneca Faslodex 5ml:0.25g
6.1.4 Interviewee, Name and Contact
6.2 Roche
6.2.1 Company Basic Information
6.2.2 Hercepti (Specification and Price)
6.2.2.1 Hercepti 440mg(20ml)/bottle, Price, Sales Value and Market Share of Roche
6.2.2.2 Hercepti 150mg(20ml)/bottle, Price, Sales Value and Market Share of Roche
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.3.1 Sales Value, Gross Margin and Growth rate of Roche Hercepti 440mg(20ml)/bottle
6.2.3.2 Sales Value, Gross Margin and Growth rate of Roche Hercepti 150mg(20ml)/bottle
6.2.4 Perjeta (Specification and Price)
6.2.4.1 Perjeta, Price, Sales Value and Market Share of Roche
6.2.5 Sales Value, Gross Margin 2011-2016
6.2.5.1 Sales Value, Gross Margin and Growth rate of Roche Perjeta
6.2.6 Kadcyla (Specification and Price)
6.2.6.1 Kadcyla, Price, Sales Value and Market Share of Roche
6.2.7 Sales Value, Gross Margin 2011-2016
6.2.7.1 Sales Value, Gross Margin and Growth rate of Roche Kadcyla
6.2.8 Avastin (Specification and Price)
6.2.8.1 Avastin, Price, Sales Value and Market Share of Roche
6.2.9 Sales Value, Gross Margin 2011-2016
6.2.9.1 Sales Value, Gross Margin and Growth rate of Roche Avastin
6.2.10 Capecitabine Tablets (Xeloda) (Specification and Price)
6.2.10.1 Capecitabine Tablets (Xeloda) 0.15g, Price, Sales Value and Market Share of Roche
6.2.10.2 Capecitabine Tablets (Xeloda) 0.5g, Price, Sales Value and Market Share of Roche
6.2.11 Sales Value, Gross Margin 2011-2016
6.2.11.1 Sales Value, Gross Margin and Growth rate of Roche Capecitabine Tablets (Xeloda) 0.15g
6.2.11.2 Sales Value, Gross Margin and Growth rate of Roche Capecitabine Tablets (Xeloda) 0.5g
6.2.12 Interviewee, Name and Contact
6.3 Novartis Pharma
6.3.1 Company Basic Information
6.3.2 Afinitor (Specification and Price)
6.3.2.1 Afinitor 5mg, Price, Sales Value and Market Share of Novartis Pharma
6.3.2.2 Afinitor 10mg, Price, Sales Value and Market Share of Novartis Pharma
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.3.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Afinitor 5mg
6.3.3.2 Sales Value, Gross Margin and Growth rate of Novartis Pharma Afinitor 10mg
6.3.4 Letrozole Tablets (Femara) (Specification and Price)
6.3.4.1 Letrozole Tablets (Femara), Price, Sales Value and Market Share of Novartis Pharma
6.3.5 Sales Value, Gross Margin 2011-2016
6.3.5.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Letrozole Tablets (Femara)
6.3.6 Interviewee, Name and Contact
6.4 Hainan Hailing Chemipharma Corporation Limited
6.4.1 Company Basic Information
6.4.2 Tamoxifen Citrate Tablets (Specification and Price)
6.4.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Hainan Hailing Chemipharma Corporation Limited
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.3.1 Sales Value, Gross Margin and Growth rate of Hainan Hailing Chemipharma Corporation Limited Tamoxifen Citrate Tablets 10mg
6.4.4 Interviewee, Name and Contact
6.5 SCRIANEN
6.5.1 Company Basic Information
6.5.2 Tamoxifen Citrate Tablets (Specification and Price)
6.5.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of SCRIANEN
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.3.1 Sales Value, Gross Margin and Growth rate of SCRIANEN Tamoxifen Citrate Tablets 10mg
6.5.4 Interviewee, Name and Contact
6.6 Changchun Dazheng Tec-Phar
6.6.1 Company Basic Information
6.6.2 Tamoxifen Citrate Tablets (Specification and Price)
6.6.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Changchun Dazheng Tec-Phar
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.3.1 Sales Value, Gross Margin and Growth rate of Changchun Dazheng Tec-Phar Tamoxifen Citrate Tablets 10mg
6.6.4 Interviewee, Name and Contact
6.7 Shenyang Funing Pharmaceuticals
6.7.1 Company Basic Information
6.7.2 Tamoxifen Citrate Tablets (Specification and Price)
6.7.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Shenyang Funing Pharmaceuticals
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.3.1 Sales Value, Gross Margin and Growth rate of Shenyang Funing Pharmaceuticals Tamoxifen Citrate Tablets 10mg
6.7.4 Interviewee, Name and Contact
6.8 NT Pharma
6.8.1 Company Basic Information
6.8.2 Tamoxifen Citrate Tablets (Specification and Price)
6.8.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of NT Pharma
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3.1 Sales Value, Gross Margin and Growth rate of NT Pharma Tamoxifen Citrate Tablets 10mg
6.8.4 Interviewee, Name and Contact
6.9 FORWARD
6.9.1 Company Basic Information
6.9.2 Tamoxifen Citrate Tablets (Specification and Price)
6.9.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of FORWARD
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.3.1 Sales Value, Gross Margin and Growth rate of FORWARD Tamoxifen Citrate Tablets 10mg
6.9.4 Interviewee, Name and Contact
6.10 Yangtze River Pharmaceutical Group
6.10.1 Company Basic Information
6.10.2 Tamoxifen Citrate Tablets (Specification and Price)
6.10.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Yangtze River Pharmaceutical Group
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.3.1 Sales Value, Gross Margin and Growth rate of Yangtze River Pharmaceutical Group Tamoxifen Citrate Tablets 10mg
6.10.4 Interviewee, Name and Contact
6.11 Liaoning Kangtai Pharmaceutical
6.11.1 Company Basic Information
6.11.2 Tamoxifen Citrate Tablets (Specification and Price)
6.11.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Liaoning Kangtai Pharmaceutical
6.11.3.1 Sales Value, Gross Margin and Growth rate of Liaoning Kangtai Pharmaceutical Tamoxifen Citrate Tablets 10mg
6.11.4 Interviewee, Name and Contact
6.12 Pfizer
6.12.1 Company Basic Information
6.12.2 Aromasin (Specification and Price)
6.12.2.1 Aromasin 25mg, Price, Sales Value and Market Share of Pfizer
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Aromasin 25mg
6.12.4 Interviewee, Name and Contact
6.13 Hainan Unipul Pharmaceutical
6.13.1 Company Basic Information
6.13.2 Exemestane Tablets (Specification and Price)
6.13.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Hainan Unipul Pharmaceutical
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.3.1 Sales Value, Gross Margin and Growth rate of Hainan Unipul Pharmaceutical Exemestane Tablets 25mg
6.13.4 Interviewee, Name and Contact
6.14 ZHPHARMA
6.14.1 Company Basic Information
6.14.2 Exemestane Tablets (Specification and Price)
6.14.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of ZHPHARMA
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.3.1 Sales Value, Gross Margin and Growth rate of ZHPHARMA Exemestane Tablets 25mg
6.14.4 Interviewee, Name and Contact
6.15 Unispharm
6.15.1 Company Basic Information
6.15.2 Exemestane Tablets (Specification and Price)
6.15.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Unispharm
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.3.1 Sales Value, Gross Margin and Growth rate of Unispharm Exemestane Tablets 25mg
6.15.4 Interviewee, Name and Contact
6.16 Qilu Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Exemestane Tablets (Specification and Price)
6.16.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.3.1 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Exemestane Tablets 25mg
6.16.4 Interviewee, Name and Contact
6.17 Zhejiang Medicine Co.,Ltd
6.17.1 Company Basic Information
6.17.2 Exemestane Tablets (Specification and Price)
6.17.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Zhejiang Medicine Co.,Ltd
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.3.1 Sales Value, Gross Margin and Growth rate of Zhejiang Medicine Co.,Ltd Exemestane Tablets 25mg
6.17.4 Interviewee, Name and Contact
6.18 Jiang Su Heng Rui Medicine
6.18.1 Company Basic Information
6.18.2 Letrozol Tablets (Specification and Price)
6.18.2.1 Letrozol Tablets, Price, Sales Value and Market Share of Jiang Su Heng Rui Medicine
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.3.1 Sales Value, Gross Margin and Growth rate of Jiang Su Heng Rui Medicine Letrozol Tablets
6.18.4 Interviewee, Name and Contact
6.19 Shanghai Roche Pharmaceutical
6.19.1 Company Basic Information
6.19.2 Capecitabine Tablets (Specification and Price)
6.19.2.1 Capecitabine Tablets 0.15g, Price, Sales Value and Market Share of Shanghai Roche Pharmaceutical
6.19.2.2 Capecitabine Tablets 0.5g, Price, Sales Value and Market Share of Shanghai Roche Pharmaceutical
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.3.1 Sales Value, Gross Margin and Growth rate of Shanghai Roche Pharmaceutical Capecitabine Tablets 0.15g
6.19.3.2 Sales Value, Gross Margin and Growth rate of Shanghai Roche Pharmaceutical Capecitabine Tablets 0.5g
6.19.4 Interviewee, Name and Contact
6.20 Pfizer
6.20.1 Company Basic Information
6.20.2 Ibrance (Specification and Price)
6.20.2.1 Ibrance, Price, Sales Value and Market Share of Pfizer
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Ibrance
6.20.4 Interviewee, Name and Contact
7 TECHNOLOGY DEVELOPMENT TREND
7.1 Manufacturing Process of Drugs for Treatment of Non-small-Cell Lung Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 WORLDWIDE, AN ESTIMATED TIME FOR THE DRUG IN LUNG CANCER RESEARCH TO MARKET
9 MAIN DUGS FOR BREAST CANCER PATENT EXPIRATION TIME ANALYSIS
10 RESEARCH FINDINGS AND CONCLUSION
1 DRUGS FOR TREATMENT OF BREAST CANCER OVERVIEW AND EACH TYPE
1.1 Product Overview of Drugs for Treatment of Breast Cancer
1.1.1 Definition and Product Scope of Drugs for Treatment of Breast Cancer
1.1.2 Global Market Size (Value and Volume) of Drugs for Treatment of Breast Cancer 2015-2020
1.1.3 China Market Size (Value and Volume) of Drugs for Treatment of Breast Cancer 2015-2020
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List of Each Type in 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Faslodex Specification and Price in 2015 and 2016
1.2.5 Hercepti Specification and Price in 2015 and 2016
1.2.6 Perjeta Specification and Price in 2015 and 2016
1.2.7 Kadcyla Specification and Price in 2015 and 2016
1.2.8 Afinitor Specification and Price in 2015 and 2016
1.2.9 Avastin Specification and Price in 2015 and 2016
1.2.10 Tamoxifen Citrate Tablets Specification and Price in 2015 and 2016
1.2.11 Exemestane Tablets Specification and Price in 2015 and 2016
1.2.12 Letrozol Tablets Specification and Price in 2015 and 2016
1.2.13 Capecitabine Tablets Specification and Price in 2015 and 2016
1.2.14 Ibrance Specification and Price in 2015 and 2016
1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.3.1 Price List (Interviewed) of Faslodex by Key Manufacturers
1.3.2 Price List (Interviewed) of Hercepti by Key Manufacturers
1.3.3 Price List (Interviewed) of Perjeta by Key Manufacturers
1.3.4 Price List (Interviewed) of Kadcyla by Key Manufacturers
1.3.5 Price List (Interviewed) of Afinitor by Key Manufacturers
1.3.6 Price List (Interviewed) of Avastin by Key Manufacturers
1.3.7 Price List (Interviewed) of Tamoxifen Citrate Tablets by Key Manufacturers
1.3.8 Price List (Interviewed) of Exemestane Tablets by Key Manufacturers
1.3.9 Price List (Interviewed) of Letrozol Tablets by Key Manufacturers
1.3.10 Price List (Interviewed) of Capecitabine Tablets by Key Manufacturers
1.3.11 Price List (Interviewed) of Ibrance by Key Manufacturers
2 COMPETITION ANALYSIS BY MANUFACTURERS IN GLOBAL AND CHINA
2.1 Global Market Drugs for Treatment of Breast Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 Global Market Drugs for Treatment of Breast Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.3 Global Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
2.4 China Market Drugs for Treatment of Breast Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.5 China Market Drugs for Treatment of Breast Cancer Revenue and Share List of Key Manufacturers 2015 to 2016
2.6 China Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
3 SALES AND REVENUE SEGMENTS OF EACH TYPE 2015 TO 2016
3.1 Global Sales and Revenue Segments of Each Type 2015 to 2016
3.1.1 Global Sales and Market Share of Each Type 2015 to 2016
3.1.2 Global Revenue and Market Share of Each Type 2015 to 2016
3.2 Faslodex Sales and Growth Rate 2015 to 2020
3.3 Hercepti Sales and Growth Rate 2015 to 2020
3.4 Perjeta Sales and Growth Rate 2015 to 2020
3.5 Kadcyla Sales and Growth Rate 2015 to 2020
3.6 Afinitor Sales and Growth Rate 2015 to 2020
3.7 Avastin Sales and Growth Rate 2015 to 2020
3.8 Tamoxifen Citrate Tablets Sales and Growth Rate 2015 to 2020
3. 9 EXEMESTANE TABLETS SALES AND GROWTH RATE 2015 TO 2020
3.10 Letrozol Tablets Sales and Growth Rate 2015 to 2020
3.11 Capecitabine Tablets Sales and Growth Rate 2015 to 2020
4 MARKET SEGMENTS AND FORECAST OF DRUGS FOR TREATMENT OF BREAST CANCER BY REGIONS
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
4.1.1 Sales and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2 Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2.1 Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
4.3 Established ROW Market Forecast to 2020
4.3.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.4 Europe Market Forecast to 2020
4.4.1 Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.5 Emerging Markets Market Forecast to 2020
4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
4.8 China Market Forecast to 2020
4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
5 RAW MATERIALS AND APPLICATIONS
5.1 Key Raw Materials and Price Analysis for Faslodex
5.1.1 Key Raw Materials for Faslodex
5.1.2 Price Forecast of Key Raw Materials for Faslodex 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Hercepti
5.2.1 Key Raw Materials for Hercepti
5.2.2 Price Forecast of Key Raw Materials for Hercepti 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Perjeta
5.3.1 Key Raw Materials for Perjeta
5.3.2 Price Forecast of Key Raw Materials for Perjeta 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Kadcyla
5.4.1 Key Raw Materials for Kadcyla
5.4.2 Price Forecast of Key Raw Materials for Kadcyla 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Afinitor
5.5.1 Key Raw Materials for Afinitor
5.5.2 Price Forecast of Key Raw Materials for Afinitor 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Avastin
5.6.1 Key Raw Materials for Avastin
5.6.2 Price Forecast of Key Raw Materials for Avastin 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Tamoxifen Citrate Tablets
5.7.1 Key Raw Materials for Tamoxifen Citrate Tablets
5.7.2 Price Forecast of Key Raw Materials for Tamoxifen Citrate Tablets 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Exemestane Tablets
5.8.1 Key Raw Materials for Exemestane Tablets
5.8.2 Price Forecast of Key Raw Materials for Exemestane Tablets 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Letrozol Tablets
5.9.1 Key Raw Materials for Letrozol Tablets
5.9.2 Price Forecast of Key Raw Materials for Letrozol Tablets 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Capecitabine Tablets
5.10.1 Key Raw Materials for Capecitabine Tablets
5.10.2 Price Forecast of Key Raw Materials for Capecitabine Tablets 2016 to 2021
5.11 Key Raw Materials and Price Analysis for Ibrance
5.11.1 Key Raw Materials for Ibrance
5.11.2 Price Forecast of Key Raw Materials for Ibrance 2016 to 2021
5.12 Applications of Faslodex
5.13 Applications of Hercepti
5.14 Applications of Perjeta
5.15 Applications of Kadcyla
5.16 Applications of Afinitor
5.17 Applications of Avastin
5.18 Applications of Tamoxifen Citrate Tablets
5.19 Applications of Exemestane Tablets
5.20 Applications of Letrozol Tablets
5.21 Applications of Capecitabine Tablets
5.22 Applications of Ibrance
6 KEY MANUFACTURERS ANALYSIS OF DRUGS FOR TREATMENT OF BREAST CANCER
6.1 AstraZeneca
6.1.1 Company Basic Information
6.1.2 Faslodex (Specification and Price)
6.1.2.1 Faslodex 5ml:0.25g, Price, Sales Value and Market Share of AstraZeneca
6.1.3 Sales Value, Gross Margin 2011-2016
6.1.3.1 Sales Value, Gross Margin and Growth rate of AstraZeneca Faslodex 5ml:0.25g
6.1.4 Interviewee, Name and Contact
6.2 Roche
6.2.1 Company Basic Information
6.2.2 Hercepti (Specification and Price)
6.2.2.1 Hercepti 440mg(20ml)/bottle, Price, Sales Value and Market Share of Roche
6.2.2.2 Hercepti 150mg(20ml)/bottle, Price, Sales Value and Market Share of Roche
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.3.1 Sales Value, Gross Margin and Growth rate of Roche Hercepti 440mg(20ml)/bottle
6.2.3.2 Sales Value, Gross Margin and Growth rate of Roche Hercepti 150mg(20ml)/bottle
6.2.4 Perjeta (Specification and Price)
6.2.4.1 Perjeta, Price, Sales Value and Market Share of Roche
6.2.5 Sales Value, Gross Margin 2011-2016
6.2.5.1 Sales Value, Gross Margin and Growth rate of Roche Perjeta
6.2.6 Kadcyla (Specification and Price)
6.2.6.1 Kadcyla, Price, Sales Value and Market Share of Roche
6.2.7 Sales Value, Gross Margin 2011-2016
6.2.7.1 Sales Value, Gross Margin and Growth rate of Roche Kadcyla
6.2.8 Avastin (Specification and Price)
6.2.8.1 Avastin, Price, Sales Value and Market Share of Roche
6.2.9 Sales Value, Gross Margin 2011-2016
6.2.9.1 Sales Value, Gross Margin and Growth rate of Roche Avastin
6.2.10 Capecitabine Tablets (Xeloda) (Specification and Price)
6.2.10.1 Capecitabine Tablets (Xeloda) 0.15g, Price, Sales Value and Market Share of Roche
6.2.10.2 Capecitabine Tablets (Xeloda) 0.5g, Price, Sales Value and Market Share of Roche
6.2.11 Sales Value, Gross Margin 2011-2016
6.2.11.1 Sales Value, Gross Margin and Growth rate of Roche Capecitabine Tablets (Xeloda) 0.15g
6.2.11.2 Sales Value, Gross Margin and Growth rate of Roche Capecitabine Tablets (Xeloda) 0.5g
6.2.12 Interviewee, Name and Contact
6.3 Novartis Pharma
6.3.1 Company Basic Information
6.3.2 Afinitor (Specification and Price)
6.3.2.1 Afinitor 5mg, Price, Sales Value and Market Share of Novartis Pharma
6.3.2.2 Afinitor 10mg, Price, Sales Value and Market Share of Novartis Pharma
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.3.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Afinitor 5mg
6.3.3.2 Sales Value, Gross Margin and Growth rate of Novartis Pharma Afinitor 10mg
6.3.4 Letrozole Tablets (Femara) (Specification and Price)
6.3.4.1 Letrozole Tablets (Femara), Price, Sales Value and Market Share of Novartis Pharma
6.3.5 Sales Value, Gross Margin 2011-2016
6.3.5.1 Sales Value, Gross Margin and Growth rate of Novartis Pharma Letrozole Tablets (Femara)
6.3.6 Interviewee, Name and Contact
6.4 Hainan Hailing Chemipharma Corporation Limited
6.4.1 Company Basic Information
6.4.2 Tamoxifen Citrate Tablets (Specification and Price)
6.4.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Hainan Hailing Chemipharma Corporation Limited
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.3.1 Sales Value, Gross Margin and Growth rate of Hainan Hailing Chemipharma Corporation Limited Tamoxifen Citrate Tablets 10mg
6.4.4 Interviewee, Name and Contact
6.5 SCRIANEN
6.5.1 Company Basic Information
6.5.2 Tamoxifen Citrate Tablets (Specification and Price)
6.5.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of SCRIANEN
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.3.1 Sales Value, Gross Margin and Growth rate of SCRIANEN Tamoxifen Citrate Tablets 10mg
6.5.4 Interviewee, Name and Contact
6.6 Changchun Dazheng Tec-Phar
6.6.1 Company Basic Information
6.6.2 Tamoxifen Citrate Tablets (Specification and Price)
6.6.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Changchun Dazheng Tec-Phar
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.3.1 Sales Value, Gross Margin and Growth rate of Changchun Dazheng Tec-Phar Tamoxifen Citrate Tablets 10mg
6.6.4 Interviewee, Name and Contact
6.7 Shenyang Funing Pharmaceuticals
6.7.1 Company Basic Information
6.7.2 Tamoxifen Citrate Tablets (Specification and Price)
6.7.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Shenyang Funing Pharmaceuticals
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.3.1 Sales Value, Gross Margin and Growth rate of Shenyang Funing Pharmaceuticals Tamoxifen Citrate Tablets 10mg
6.7.4 Interviewee, Name and Contact
6.8 NT Pharma
6.8.1 Company Basic Information
6.8.2 Tamoxifen Citrate Tablets (Specification and Price)
6.8.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of NT Pharma
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3.1 Sales Value, Gross Margin and Growth rate of NT Pharma Tamoxifen Citrate Tablets 10mg
6.8.4 Interviewee, Name and Contact
6.9 FORWARD
6.9.1 Company Basic Information
6.9.2 Tamoxifen Citrate Tablets (Specification and Price)
6.9.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of FORWARD
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.3.1 Sales Value, Gross Margin and Growth rate of FORWARD Tamoxifen Citrate Tablets 10mg
6.9.4 Interviewee, Name and Contact
6.10 Yangtze River Pharmaceutical Group
6.10.1 Company Basic Information
6.10.2 Tamoxifen Citrate Tablets (Specification and Price)
6.10.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Yangtze River Pharmaceutical Group
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.3.1 Sales Value, Gross Margin and Growth rate of Yangtze River Pharmaceutical Group Tamoxifen Citrate Tablets 10mg
6.10.4 Interviewee, Name and Contact
6.11 Liaoning Kangtai Pharmaceutical
6.11.1 Company Basic Information
6.11.2 Tamoxifen Citrate Tablets (Specification and Price)
6.11.2.1 Tamoxifen Citrate Tablets 10mg, Price, Sales Value and Market Share of Liaoning Kangtai Pharmaceutical
6.11.3.1 Sales Value, Gross Margin and Growth rate of Liaoning Kangtai Pharmaceutical Tamoxifen Citrate Tablets 10mg
6.11.4 Interviewee, Name and Contact
6.12 Pfizer
6.12.1 Company Basic Information
6.12.2 Aromasin (Specification and Price)
6.12.2.1 Aromasin 25mg, Price, Sales Value and Market Share of Pfizer
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Aromasin 25mg
6.12.4 Interviewee, Name and Contact
6.13 Hainan Unipul Pharmaceutical
6.13.1 Company Basic Information
6.13.2 Exemestane Tablets (Specification and Price)
6.13.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Hainan Unipul Pharmaceutical
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.3.1 Sales Value, Gross Margin and Growth rate of Hainan Unipul Pharmaceutical Exemestane Tablets 25mg
6.13.4 Interviewee, Name and Contact
6.14 ZHPHARMA
6.14.1 Company Basic Information
6.14.2 Exemestane Tablets (Specification and Price)
6.14.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of ZHPHARMA
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.3.1 Sales Value, Gross Margin and Growth rate of ZHPHARMA Exemestane Tablets 25mg
6.14.4 Interviewee, Name and Contact
6.15 Unispharm
6.15.1 Company Basic Information
6.15.2 Exemestane Tablets (Specification and Price)
6.15.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Unispharm
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.3.1 Sales Value, Gross Margin and Growth rate of Unispharm Exemestane Tablets 25mg
6.15.4 Interviewee, Name and Contact
6.16 Qilu Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Exemestane Tablets (Specification and Price)
6.16.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Qilu Pharmaceutical
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.3.1 Sales Value, Gross Margin and Growth rate of Qilu Pharmaceutical Exemestane Tablets 25mg
6.16.4 Interviewee, Name and Contact
6.17 Zhejiang Medicine Co.,Ltd
6.17.1 Company Basic Information
6.17.2 Exemestane Tablets (Specification and Price)
6.17.2.1 Exemestane Tablets 25mg, Price, Sales Value and Market Share of Zhejiang Medicine Co.,Ltd
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.3.1 Sales Value, Gross Margin and Growth rate of Zhejiang Medicine Co.,Ltd Exemestane Tablets 25mg
6.17.4 Interviewee, Name and Contact
6.18 Jiang Su Heng Rui Medicine
6.18.1 Company Basic Information
6.18.2 Letrozol Tablets (Specification and Price)
6.18.2.1 Letrozol Tablets, Price, Sales Value and Market Share of Jiang Su Heng Rui Medicine
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.3.1 Sales Value, Gross Margin and Growth rate of Jiang Su Heng Rui Medicine Letrozol Tablets
6.18.4 Interviewee, Name and Contact
6.19 Shanghai Roche Pharmaceutical
6.19.1 Company Basic Information
6.19.2 Capecitabine Tablets (Specification and Price)
6.19.2.1 Capecitabine Tablets 0.15g, Price, Sales Value and Market Share of Shanghai Roche Pharmaceutical
6.19.2.2 Capecitabine Tablets 0.5g, Price, Sales Value and Market Share of Shanghai Roche Pharmaceutical
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.3.1 Sales Value, Gross Margin and Growth rate of Shanghai Roche Pharmaceutical Capecitabine Tablets 0.15g
6.19.3.2 Sales Value, Gross Margin and Growth rate of Shanghai Roche Pharmaceutical Capecitabine Tablets 0.5g
6.19.4 Interviewee, Name and Contact
6.20 Pfizer
6.20.1 Company Basic Information
6.20.2 Ibrance (Specification and Price)
6.20.2.1 Ibrance, Price, Sales Value and Market Share of Pfizer
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.3.1 Sales Value, Gross Margin and Growth rate of Pfizer Ibrance
6.20.4 Interviewee, Name and Contact
7 TECHNOLOGY DEVELOPMENT TREND
7.1 Manufacturing Process of Drugs for Treatment of Non-small-Cell Lung Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 WORLDWIDE, AN ESTIMATED TIME FOR THE DRUG IN LUNG CANCER RESEARCH TO MARKET
9 MAIN DUGS FOR BREAST CANCER PATENT EXPIRATION TIME ANALYSIS
10 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Drugs for Treatment of Breast Cancer
Figure Global Market Size (Value) of Drugs for Treatment of Breast Cancer 2015-2020
Figure Global Market Size (Volume) of Drugs for Treatment of Breast Cancer 2015-2020
Figure China Market Size (Value) of Drugs for Treatment of Breast Cancer 2015-2020
Figure China Market Size (Volume) of Drugs for Treatment of Breast Cancer 2015-2020
Table Product Type of Key Manufacturers
Table Price List of Each Type
Table Market Share of Each Type
Figure Growth Rate of Each Type 2015 to 2016
Figure Picture of Faslodex
Table Specification and Price of Faslodex in 2015 and 2016
Figure Picture of Hercepti
Table Specification and Price of Hercepti in 2015 and 2016
Figure Picture of Perjeta
Table Specification and Price of Perjeta in 2015 and 2016
Figure Picture of Kadcyla
Table Specification and Price of Kadcyla in 2015 and 2016
Figure Picture of Afinitor
Table Specification and Price of Afinitor in 2015 and 2016
Figure Picture of Avastin
Table Specification and Price of Avastin in 2015 and 2016
Figure Picture of Tamoxifen Citrate Tablets
Table Specification and Price of Tamoxifen Citrate Tablets in 2015 and 2016
Figure Picture of Exemestane Tablets
Table Specification and Price of Exemestane Tablets in 2015 and 2016
Figure Picture of Letrozol Tablets
Table Specification and Price of Letrozol Tablets in 2015 and 2016
Figure Picture of Capecitabine Tablets
Table Specification and Price of Capecitabine Tablets in 2015 and 2016
Figure Picture of Ibrance
Table Specification and Price of Ibrance in 2015 and 2016
Table Price List (Interviewed) of Faslodex by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Hercepti by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Perjeta by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Kadcyla by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Afinitor by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Avastin by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Tamoxifen Citrate Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Exemestane Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Letrozol Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Capecitabine Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Ibrance by Key Manufacturers in 2015 and 2016
Table Global Market Drugs for Treatment of Breast Cancer Sales List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Revenue List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table Global Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Sales List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Revenue List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table China Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
Table Global Sales of Each Type 2015 to 2016
Table Global Sales Market Share of Each Type 2015 to 2016
Table Global Revenue of Each Type 2015 to 2016
Table Global Revenue Market Share of Each Type 2015 to 2016
Figure Faslodex Sales and Growth Rate 2015 to 2020
Figure Hercepti Sales and Growth Rate 2015 to 2020
Figure Perjeta Sales and Growth Rate 2015 to 2020
Figure Kadcyla Sales and Growth Rate 2015 to 2020
Figure Afinitor Sales and Growth Rate 2015 to 2020
Figure Avastin Sales and Growth Rate 2015 to 2020
Figure Tamoxifen Citrate Tablets Sales and Growth Rate 2015 to 2020
Figure Exemestane Tablets Sales and Growth Rate 2015 to 2020
Figure Letrozol Tablets Sales and Growth Rate 2015 to 2020
Figure Capecitabine Tablets Sales and Growth Rate 2015 to 2020
Table Sales and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
Figure Sales Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Table Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Figure Production Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Table Established ROW Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Europe Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Emerging Markets Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table China Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Key Raw Materials for Faslodex
Table Price Forecast of Key Raw Materials for Faslodex
Table Key Raw Materials for Hercepti
Table Price Forecast of Key Raw Materials for Hercepti
Table Key Raw Materials for Perjeta
Table Price Forecast of Key Raw Materials for Perjeta
Table Key Raw Materials for Kadcyla
Table Price Forecast of Key Raw Materials for Kadcyla
Table Key Raw Materials for Afinitor
Table Price Forecast of Key Raw Materials for Afinitor
Table Key Raw Materials for Avastin
Table Price Forecast of Key Raw Materials for Avastin
Table Key Raw Materials for Tamoxifen Citrate Tablets
Table Price Forecast of Key Raw Materials for Tamoxifen Citrate Tablets
Table Key Raw Materials for Exemestane Tablets
Table Price Forecast of Key Raw Materials for Exemestane Tablets
Table Key Raw Materials for Letrozol Tablets
Table Price Forecast of Key Raw Materials for Letrozol Tablets
Table Key Raw Materials for Capecitabine Tablets
Table Price Forecast of Key Raw Materials for Capecitabine Tablets
Table Key Raw Materials for Ibrance
Table Price Forecast of Key Raw Materials for Ibrance
Table Applications of Faslodex
Table Applications of Hercepti
Table Applications of Perjeta
Table Applications of Kadcyla
Table Applications of Afinitor
Table Applications of Avastin
Table Applications of Tamoxifen Citrate Tablets
Table Applications of Exemestane Tablets
Table Applications of Letrozol Tablets
Table Applications of Capecitabine Tablets
Table Applications of Ibrance
Table AstraZeneca Basic Information List
Table Roche Basic Information List
Table Novartis Pharma Basic Information List
Table Hainan Hailing Chemipharma Corporation Limited Basic Information List
Table SCRIANEN Basic Information List
Table Changchun Dazheng Tec-Phar Basic Information List
Table Shenyang Funing Pharmaceuticals Basic Information List
Table NT Pharma Basic Information List
Table FORWARD Basic Information List
Table Yangtze River Pharmaceutical Group Basic Information List
Table Liaoning Kangtai Pharmaceutical Basic Information List
Table Pfizer Basic Information List
Table Hainan Unipul Pharmaceutical Basic Information List
Table ZHPHARMA Basic Information List
Table Unispharm Basic Information List
Table Qilu Pharmaceutical Basic Information List
Table Zhejiang Medicine Co.,Ltd Basic Information List
Table Jiang Su Heng Rui Medicine Basic Information List
Table Shanghai Roche Pharmaceutical Basic Information List
Table Pfizer Information List
Figure Picture of Drugs for Treatment of Breast Cancer
Figure Global Market Size (Value) of Drugs for Treatment of Breast Cancer 2015-2020
Figure Global Market Size (Volume) of Drugs for Treatment of Breast Cancer 2015-2020
Figure China Market Size (Value) of Drugs for Treatment of Breast Cancer 2015-2020
Figure China Market Size (Volume) of Drugs for Treatment of Breast Cancer 2015-2020
Table Product Type of Key Manufacturers
Table Price List of Each Type
Table Market Share of Each Type
Figure Growth Rate of Each Type 2015 to 2016
Figure Picture of Faslodex
Table Specification and Price of Faslodex in 2015 and 2016
Figure Picture of Hercepti
Table Specification and Price of Hercepti in 2015 and 2016
Figure Picture of Perjeta
Table Specification and Price of Perjeta in 2015 and 2016
Figure Picture of Kadcyla
Table Specification and Price of Kadcyla in 2015 and 2016
Figure Picture of Afinitor
Table Specification and Price of Afinitor in 2015 and 2016
Figure Picture of Avastin
Table Specification and Price of Avastin in 2015 and 2016
Figure Picture of Tamoxifen Citrate Tablets
Table Specification and Price of Tamoxifen Citrate Tablets in 2015 and 2016
Figure Picture of Exemestane Tablets
Table Specification and Price of Exemestane Tablets in 2015 and 2016
Figure Picture of Letrozol Tablets
Table Specification and Price of Letrozol Tablets in 2015 and 2016
Figure Picture of Capecitabine Tablets
Table Specification and Price of Capecitabine Tablets in 2015 and 2016
Figure Picture of Ibrance
Table Specification and Price of Ibrance in 2015 and 2016
Table Price List (Interviewed) of Faslodex by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Hercepti by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Perjeta by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Kadcyla by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Afinitor by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Avastin by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Tamoxifen Citrate Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Exemestane Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Letrozol Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Capecitabine Tablets by Key Manufacturers in 2015 and 2016
Table Price List (Interviewed) of Ibrance by Key Manufacturers in 2015 and 2016
Table Global Market Drugs for Treatment of Breast Cancer Sales List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Revenue List of Key Manufacturers 2015 to 2016
Table Global Market Drugs for Treatment of Breast Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table Global Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Sales List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Sales Share List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Revenue List of Key Manufacturers 2015 to 2016
Table China Market Drugs for Treatment of Breast Cancer Revenue Share List of Key Manufacturers 2015 to 2016
Table China Drugs for Treatment of Breast Cancer Average Price List of Key Manufacturers 2015 to 2016
Table Global Sales of Each Type 2015 to 2016
Table Global Sales Market Share of Each Type 2015 to 2016
Table Global Revenue of Each Type 2015 to 2016
Table Global Revenue Market Share of Each Type 2015 to 2016
Figure Faslodex Sales and Growth Rate 2015 to 2020
Figure Hercepti Sales and Growth Rate 2015 to 2020
Figure Perjeta Sales and Growth Rate 2015 to 2020
Figure Kadcyla Sales and Growth Rate 2015 to 2020
Figure Afinitor Sales and Growth Rate 2015 to 2020
Figure Avastin Sales and Growth Rate 2015 to 2020
Figure Tamoxifen Citrate Tablets Sales and Growth Rate 2015 to 2020
Figure Exemestane Tablets Sales and Growth Rate 2015 to 2020
Figure Letrozol Tablets Sales and Growth Rate 2015 to 2020
Figure Capecitabine Tablets Sales and Growth Rate 2015 to 2020
Table Sales and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015-2020
Figure Sales Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Table Production and Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Figure Production Growth Rate Forecast of Drugs for Treatment of Breast Cancer by Regions 2015 to 2020
Table Established ROW Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Europe Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Emerging Markets Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table China Sales, Production, Import and Export of Drugs for Treatment of Breast Cancer 2015 to 2020
Table Key Raw Materials for Faslodex
Table Price Forecast of Key Raw Materials for Faslodex
Table Key Raw Materials for Hercepti
Table Price Forecast of Key Raw Materials for Hercepti
Table Key Raw Materials for Perjeta
Table Price Forecast of Key Raw Materials for Perjeta
Table Key Raw Materials for Kadcyla
Table Price Forecast of Key Raw Materials for Kadcyla
Table Key Raw Materials for Afinitor
Table Price Forecast of Key Raw Materials for Afinitor
Table Key Raw Materials for Avastin
Table Price Forecast of Key Raw Materials for Avastin
Table Key Raw Materials for Tamoxifen Citrate Tablets
Table Price Forecast of Key Raw Materials for Tamoxifen Citrate Tablets
Table Key Raw Materials for Exemestane Tablets
Table Price Forecast of Key Raw Materials for Exemestane Tablets
Table Key Raw Materials for Letrozol Tablets
Table Price Forecast of Key Raw Materials for Letrozol Tablets
Table Key Raw Materials for Capecitabine Tablets
Table Price Forecast of Key Raw Materials for Capecitabine Tablets
Table Key Raw Materials for Ibrance
Table Price Forecast of Key Raw Materials for Ibrance
Table Applications of Faslodex
Table Applications of Hercepti
Table Applications of Perjeta
Table Applications of Kadcyla
Table Applications of Afinitor
Table Applications of Avastin
Table Applications of Tamoxifen Citrate Tablets
Table Applications of Exemestane Tablets
Table Applications of Letrozol Tablets
Table Applications of Capecitabine Tablets
Table Applications of Ibrance
Table AstraZeneca Basic Information List
Table Roche Basic Information List
Table Novartis Pharma Basic Information List
Table Hainan Hailing Chemipharma Corporation Limited Basic Information List
Table SCRIANEN Basic Information List
Table Changchun Dazheng Tec-Phar Basic Information List
Table Shenyang Funing Pharmaceuticals Basic Information List
Table NT Pharma Basic Information List
Table FORWARD Basic Information List
Table Yangtze River Pharmaceutical Group Basic Information List
Table Liaoning Kangtai Pharmaceutical Basic Information List
Table Pfizer Basic Information List
Table Hainan Unipul Pharmaceutical Basic Information List
Table ZHPHARMA Basic Information List
Table Unispharm Basic Information List
Table Qilu Pharmaceutical Basic Information List
Table Zhejiang Medicine Co.,Ltd Basic Information List
Table Jiang Su Heng Rui Medicine Basic Information List
Table Shanghai Roche Pharmaceutical Basic Information List
Table Pfizer Information List
